ConductScience.org, home

Paper28293036

Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. II. Structure elucidation.

Fukumoto A and 7 others. J Antibiot (Tokyo), 2017. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. II. Structure elucidation. Papers, record 28293036. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28293036

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. II. Structure elucidation.
PubMed
Journal
J Antibiot (Tokyo)
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.47
iCite
Revised in PubMed
2026-10-10
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fukumoto AAtsushi
2Kim YPYong-Pil
3Iwatsuki MMasato
4Hirose TTomoyasu
5Sunazuka TToshiaki
6Hanaki HHideaki
7Ōmura SSatoshi
8Shiomi KKazuro

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Methicillin-Resistant Staphylococcus aureusMajor topic
StreptomycesMajor topic
beta-Lactam ResistanceMajor topic
Crystallography, X-Ray
Magnetic Resonance Spectroscopy
Spectrum Analysis
beta-Lactams

Source PubMed

Download CSV of topics

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13866512[Experimental study of the antitumor anthracycline antibiotic aclarubicin (aclacinomycin A)].Antibiot Med Biotekhnol1985https://conductscience.org/library/papers/3866512PubMed
23460987Anthracycline metabolites of tetracenomycin C-nonproducing Streptomyces glaucescens mutants.J Bacteriol1986https://conductscience.org/library/papers/3460987PubMed
322224500Environmental DNA-encoded antibiotics fasamycins A and B inhibit FabF in type II fatty acid biosynthesis.J Am Chem Soc2012https://conductscience.org/library/papers/22224500PubMed
418305353Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.J Antibiot (Tokyo)2008https://conductscience.org/library/papers/18305353PubMed
518305352
Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation.
J Antibiot (Tokyo)2008https://conductscience.org/library/papers/18305352PubMed
617631493Investigation of early tailoring reactions in the oxytetracycline biosynthetic pathway.J Biol Chem2007https://conductscience.org/library/papers/17631493PubMed
720192240Tetracenoquinocin and 5-iminoaranciamycin from a sponge-derived Streptomyces sp. Sp080513GE-26.J Nat Prod2010https://conductscience.org/library/papers/20192240PubMed
821768346Functional analysis of environmental DNA-derived type II polyketide synthases reveals structurally diverse secondary metabolites.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21768346PubMed
928293038
Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. I. The taxonomy of the producing strain, and the fermentation, isolation and antibacterial activities.
J Antibiot (Tokyo)2017https://conductscience.org/library/papers/28293038PubMed
1018585915The role of virulence determinants in community-associated MRSA pathogenesis.Trends Microbiol2008https://conductscience.org/library/papers/18585915PubMed

Download CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
41988676Using X-ray Crystallography and 1,n-ADEQUATE NMR to Revise the Structures of Highly Substituted Aromatic Natural Products: The Absolute Configuration of Formicamycin Congeners.J Nat Prod2026https://conductscience.org/library/papers/41988676PubMed
39265189Total Synthesis of the Phenylnaphthacenoid Type II Polyketide Antibiotic Formicamycin H via Regioselective Ruthenium-Catalyzed Hydrogen Auto-Transfer [4 + 2] Cycloaddition.J Am Chem Soc2024https://conductscience.org/library/papers/39265189PubMed
38446858An unusual aromatase/cyclase programs the formation of the phenyldimethylanthrone framework in anthrabenzoxocinones and fasamycin.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/38446858PubMed
36985714A Convenient Diels-Alder Approach toward Potential Polyketide-like Antibiotics Using α-Activated α,β-Unsaturated 4,4-Dimethyl-1-tetralones as Dienophiles.Molecules2023https://conductscience.org/library/papers/36985714PubMed
33092156Discovery of New Antibacterial Accramycins from a Genetic Variant of the Soil Bacterium, Streptomyces sp. MA37.Biomolecules2020https://conductscience.org/library/papers/33092156PubMed
31533358Accramycin A, a New Aromatic Polyketide, from the Soil Bacterium, Streptomyces sp. MA37.Molecules2019https://conductscience.org/library/papers/31533358PubMed
28293038
Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. I. The taxonomy of the producing strain, and the fermentation, isolation and antibacterial activities.
J Antibiot (Tokyo)2017https://conductscience.org/library/papers/28293038PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28293036

GET https://conductscience.org/api/papers/v1/28293036/authors